Search

Your search keyword '"Monoranu, Camelia-Maria"' showing total 358 results

Search Constraints

Start Over You searched for: Author "Monoranu, Camelia-Maria" Remove constraint Author: "Monoranu, Camelia-Maria"
358 results on '"Monoranu, Camelia-Maria"'

Search Results

1. Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation

5. Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome

7. ATRT–SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance

11. Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson’s disease mice

12. New Aspects Regarding the Fluorescence Spectra of Melanin and Neuromelanin in Pigmented Human Tissue Concerning Hypoxia.

14. DNA methylation-based classification of central nervous system tumours.

16. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

19. α-Synuclein in Parkinson’s disease: causal or bystander?

21. High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with Treg depletion

22. Characterization and Optimization of the Tumor Microenvironment in Patient-Derived Organotypic Slices and Organoid Models of Glioblastoma

23. Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features

25. Human dorsal root ganglia after plexus injury: either preservation or loss of the multicellular unit

26. TMEM119-Positive Microglial Cells in Cerebrospinal Fluid as a Possible Marker for the Inflammatory Response After Aneurysmal Subarachnoid Hemorrhage, a Preliminary Study

31. A multiplex pedigree with pathologically confirmed multiple system atrophy and Parkinson’s disease with dementia

32. [18F]FET-PET in children and adolescents with central nervous system tumors: does it support difficult clinical decision-making?

33. Identifizierung neuer Antigene bei NF2-assoziierten Vestibularisschwannomen und Malignen Peripheren Nervenscheidentumoren für CAR-T-Zell-Therapie

34. Ex vivo Organoide spiegeln die intertumorale Heterogenität des ursprünglichen Glioblastoms wider

35. Charakterisierung der RNA Expression von acht für die Immuntherapie von Glioblastomen relevanten Antigenen durch qPCR

37. IMMU-07. Interim analysis of the HIT-HGG Rez Immunvac study - Dendritic cell vaccination with partial Treg depletion and double checkpoint blockade in children with relapsed high-grade gliomas.

38. MEDB-04. Young children with metastatic medulloblastoma: frequent requirement for radiotherapy in children with non-WNT/non-SHH medulloblastoma despite highly intensified chemotherapy – Results of the MET-HIT2000-BIS4 trial

40. Additional file 1 of Insulin-like growth factor 5 associates with human Aß plaques and promotes cognitive impairment

41. Additional file 3 of Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma

42. Additional file 4 of Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma

46. SOAT1: A Suitable Target for Therapy in High-Grade Astrocytic Glioma?

47. Effects of long-term temozolomide treatment on stem-like GBM cells with different molecular profiles

48. Dopamine Modulates TrkB Turnover and BDNF Sensitivity in Striatal Medium Spiny Neurons

50. Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors

Catalog

Books, media, physical & digital resources